High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Clinical trial NCT00003641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00003641
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-03-25
- Primary completion
- 2015-01-01
- Enrollment
- 1150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.